Ervant Maksabedian Hernandez
About Ervant Maksabedian Hernandez
Ervant Maksabedian Hernandez is the Health Economics Director at Bristol Myers Squibb in Princeton, New Jersey. He has extensive experience in health economics and policy analysis, having previously held various roles at Amgen, RAND Corporation, and other organizations.
Current Title and Position
Ervant Maksabedian Hernandez currently holds the position of Health Economics Director at Bristol Myers Squibb in Princeton, New Jersey, United States. In this role, he is responsible for overseeing health economics initiatives within the organization.
Previous Experience at Amgen
Before joining Bristol Myers Squibb, Ervant Maksabedian Hernandez accumulated diverse experience at Amgen across several roles. He began as a Health Economics Manager from 2017 to 2019 in the Greater Los Angeles Area. He then served as Health Economics Senior Manager from 2019 to 2021. In 2021, he transitioned to Health Economics Oncology Senior Manager, and later held the role of Value & Access - Oncology Senior Manager until 2022.
Early Career and Roles
Ervant Maksabedian Hernandez's early career includes working as an Assistant Policy Researcher at RAND Corporation from 2012 to 2017 in Santa Monica. He also served as a Research Analyst at Secretaria de Finanzas del Gobierno del Estado de Mexico in Toluca, Mexico, in 2012. Prior to that, he was a Policy Analyst at Microsoft in Mexico City area during 2011 and an Associate Consultant at Policy and Management Consulting from 2009 to 2011 in Mexico City.
Educational Background
Ervant Maksabedian Hernandez earned a Doctor of Philosophy (Ph.D.) and a Master of Philosophy (MPhil.) in Public Policy Analysis with a focus on Health Economics and Quantitative Methods from Pardee RAND Graduate School, studying from 2012 to 2017. He also holds a Bachelor's Degree in Economics from Centro de Investigación y Docencia Económicas, obtained between 2004 and 2008.
Technical Skills and Expertise
Ervant Maksabedian Hernandez has substantial expertise in statistical programming, with proficiency in tools such as Stata and R. His skill set encompasses econometrics, data science, experimental design and implementation, and policy evaluation, further solidifying his expertise in health economics.